合成或自体颅骨修补术后感染需手术干预的发生率:一项全国再入院数据库分析
该研究利用美国全国再入院数据库(NRD)分析2015年10月至2018年12月因外伤性脑损伤(TBI)或卒中后行择期自体骨瓣(ABF)或合成骨瓣(SF)颅骨修补的住院病例,评估临床利用、相关费用及术后感染风险。结果显示SF使用比例增加且费用更高,SF患者因感染再手术率高于ABF,女性、非例行出院和SF修补与再手术风险增加相关。
要点
- 2015年10月至2018年12月美国估计完成2295例SF和2072例ABF颅骨修补术。
- SF颅骨修补术中位总住院费用比ABF高31,200美元(p < 0.001)。
- SF患者122例(5.3%)因感染再入院手术,ABF患者70例(3.4%)。
核心结论
- SF正日益取代ABF成为颅骨修补的首选材料,尽管其与住院费用增加相关。
- 女性、非例行出院和SF颅骨修补与颅骨修补后再手术风险增加相关。
研究设计与样本
- 使用公开的美国全国再入院数据库(NRD)识别2015年10月至2018年12月因TBI或卒中后行择期ABF或SF颅骨修补的索引住院。
- 对后续再入院中因感染或疑似感染接受神经外科干预的患者进一步分析,使用调查Cox比例风险模型评估再入院风险。
主要发现
- 研究期间颅骨修补手术总数下降,但使用SF的比例增加(p < 0.001),尤其在男性患者(p = 0.011)和TBI患者(对比卒中,p = 0.012)中。
- SF颅骨修补的中位总住院费用比ABF颅骨修补高31,200美元(p < 0.001)。
- 所有首次再入院中,20%涉及因感染原因的手术治疗。
- 总体中,122例SF患者(5.3%)在再入院时因感染接受手术治疗,而ABF患者为70例(3.4%)。
- 多变量Cox模型校正混杂因素后,女性(对比男性,p = 0.003)、非例行出院(对比出院回家或自我照护,p < 0.001)和SF颅骨修补(对比ABF,p = 0.011)更可能因再手术再入院;较近年份(如2018年对比2015年)行颅骨修补的患者因感染再手术再入院的可能性更低(p = 0.024)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to characterize the clinical utilization and associated charges of autologous bone flap (ABF) versus synthetic flap (SF) cranioplasty and to characterize the postoperative infection risk of SF versus ABF using the National Readmissions Database (NRD). METHODS: The authors used the publicly available NRD to identify index hospitalizations from October 2015 to December 2018 involving elective ABF or SF cranioplasty after traumatic brain injury (TBI) or stroke. Subsequent readmissions were further characterized if patients underwent neurosurgical intervention for treatment of infection or suspected infection. Survey Cox proportional hazards models were used to assess risk of readmission. RESULTS: An estimated 2295 SF and 2072 ABF cranioplasties were performed from October 2015 to December 2018 in the United States. While the total number of cranioplasty operations decreased during the study period, the proportion of cranioplasties utilizing SF increased (p < 0.001), particularly in male patients (p = 0.011) and those with TBI (vs stroke, p = 0.012). The median total hospital charge for SF cranioplasty was $31,200 more costly than ABF cranioplasty (p < 0.001). Of all first-time readmissions, 20% involved surgical treatment for infectious reasons. Overall, 122 SF patients (5.3%) underwent surgical treatment of infection compared with 70 ABF patients (3.4%) on readmission. After accounting for confounders using a multivariable Cox model, female patients (vs male, p = 0.003), those discharged nonroutinely (vs discharge to home or self-care, p < 0.001), and patients who underwent SF cranioplasty (vs ABF, p = 0.011) were more likely to be readmitted for reoperation. Patients undergoing cranioplasty during more recent years (e.g., 2018 vs 2015) were less likely to be readmitted for reoperation because of infection (p = 0.024). CONCLUSIONS: SFs are increasingly replacing ABFs as the material of choice for cranioplasty, despite their association with increased hospital charges. Female sex, nonroutine discharge, and SF cranioplasty are associated with increased risk for reoperation after cranioplasty.
引用
- Do TH, Lu J, Palzer EF, et al. Rates of operative intervention for infection after synthetic or autologous cranioplasty: a National Readmissions Database analysis. J Neurosurg. 2022. PMID: 35901766. doi:10.3171/2022.4.JNS22301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。